1. Home
  2. EEIQ vs HCWB Comparison

EEIQ vs HCWB Comparison

Compare EEIQ & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$5.37

Market Cap

5.1M

Sector

Real Estate

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.77

Market Cap

5.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEIQ
HCWB
Founded
2017
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.0M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
EEIQ
HCWB
Price
$5.37
$1.77
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $35.00
AVG Volume (30 Days)
14.8K
★ 819.2K
Earning Date
01-28-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.25
52 Week High
$12.70
$5.61

Technical Indicators

Market Signals
Indicator
EEIQ
HCWB
Relative Strength Index (RSI) 80.29 36.26
Support Level $2.31 $0.97
Resistance Level $5.36 $3.90
Average True Range (ATR) 0.34 0.28
MACD 0.13 -0.02
Stochastic Oscillator 85.31 10.60

Price Performance

Historical Comparison
EEIQ
HCWB

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: